Capital International Investors’s CVS Health CVS Stock Holding History

Capital International Investors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.11B	Sell	15,392,222 -12,200,134	-44%	-$940M	0.26%	91
2025 Q4	$2.19B	Buy	27,592,356 +900,153	+3%	+$71M	0.34%	66
2025 Q3	$2.01B	Buy	26,692,203 +302,499	+1%	+$20.7M	0.32%	72
2025 Q2	$1.82B	Buy	26,389,704 +202,046	+0.8%	+$13.2M	0.31%	77
2025 Q1	$1.77B	Sell	26,187,658 -478,743	-2%	-$28.6M	0.35%	76
2024 Q4	$1.2B	Buy	26,666,401 +1,212,126	+5%	+$68M	0.22%	95
2024 Q3	$1.6B	Buy	25,454,275 +4,716,600	+23%	+$275M	0.31%	80
2024 Q2	$1.22B	Sell	20,737,675 -17,180,248	-45%	-$1.07B	0.25%	90
2024 Q1	$3.02B	Buy	37,917,923 +4,226,225	+13%	+$323M	0.61%	44
2023 Q4	$2.66B	Buy	33,691,698 +10,837,801	+47%	+$771M	0.6%	45
2023 Q3	$1.6B	Buy	22,853,897 +20,033,737	+710%	+$1.42B	0.4%	72
2023 Q2	$195M	Sell	2,820,160 -2,272,787	-45%	-$162M	0.05%	231
2023 Q1	$378M	Sell	5,092,947 -20,957,031	-80%	-$1.76B	0.1%	179
2022 Q4	$2.43B	Buy	26,049,978 +142,488	+0.5%	+$13.7M	0.65%	37
2022 Q3	$2.47B	Sell	25,907,490 -351,533	-1%	-$34.8M	0.72%	33
2022 Q2	$2.43B	Sell	26,259,023 -1,880,475	-7%	-$184M	0.66%	38
2022 Q1	$2.85B	Buy	28,139,498 +318,021	+1%	+$33.4M	0.65%	39
2021 Q4	$2.87B	Buy	27,821,477 +414,724	+2%	+$38.3M	0.61%	38
2021 Q3	$2.33B	Buy	27,406,753 +6,241	+0%	+$523K	0.53%	49
2021 Q2	$2.29B	Buy	27,400,512 +9,809,050	+56%	+$803M	0.52%	48
2021 Q1	$1.32B	Buy	17,591,462 +1,548	+0%	+$113K	0.33%	83
2020 Q4	$1.2B	Buy	17,589,914 +4,178,796	+31%	+$272M	0.33%	86
2020 Q3	$783M	Sell	13,411,118 -11,371,330	-46%	-$708M	0.24%	107
2020 Q2	$1.61B	Buy	24,782,448 +13,399	+0.1%	+$844K	0.53%	45
2020 Q1	$1.47B	Buy	24,769,049 +25,962	+0.1%	+$1.73M	0.6%	43
2019 Q4	$1.84B	Buy	24,743,087 +444,995	+2%	+$31.2M	0.62%	41
2019 Q3	$1.53B	Buy	24,298,092 +1,704,562	+8%	+$101M	0.59%	47
2019 Q2	$1.23B	Buy	22,593,530 +7,401	+0%	+$399K	0.49%	55
2019 Q1	$1.22B	Buy	22,586,129 +3,999,974	+22%	+$247M	0.52%	55
2018 Q4	$1.22B	Buy	18,586,155 +9,424,667	+103%	+$704M	0.61%	45
2018 Q3	$721M	Buy	9,161,488 +9,000,188	+5,580%	+$643M	0.33%	82
2018 Q2	$10.4M	Hold	161,300	–	–	0.01%	217
2018 Q1	$10M	Sell	161,300 -1,993,000	-93%	-$143M	0.01%	220
2017 Q4	$156M	Sell	2,154,300 -560,700	-21%	-$40.8M	0.18%	133
2017 Q3	$221M	Hold	2,715,000	–	–	0.26%	114
2017 Q2	$218M	Hold	2,715,000	–	–	0.29%	107
2017 Q1	$213M	Hold	2,715,000	–	–	0.29%	105
2016 Q4	$214M	Hold	2,715,000	–	–	0.31%	102
2016 Q3	$242M	Hold	2,715,000	–	–	0.35%	97
2016 Q2	$260M	Hold	2,715,000	–	–	0.38%	82
2016 Q1	$282M	Hold	2,715,000	–	–	0.43%	76
2015 Q4	$265M	Hold	2,715,000	–	–	0.41%	75
2015 Q3	$262M	Hold	2,715,000	–	–	0.48%	75
2015 Q2	$285M	Hold	2,715,000	–	–	0.48%	72
2015 Q1	$280M	Hold	2,715,000	–	–	0.51%	68
2014 Q4	$261M	Hold	2,715,000	–	–	0.53%	60
2014 Q3	$216M	Hold	2,715,000	–	–	0.53%	61
2014 Q2	$205M	Hold	2,715,000	–	–	0.53%	68
2014 Q1	$203M	Hold	2,715,000	–	–	0.55%	66
2013 Q4	$194M	Hold	2,715,000	–	–	0.6%	62
2013 Q3	$154M	Sell	2,715,000 -1,330,000	-33%	-$79.3M	0.66%	65
2013 Q2	$231M	Buy	+4,045,000	New	+$234M	1.05%	19

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital International Investors's CVS Position: Q1 2026 in Review

Capital International Investors reduced its CVS Health (CVS) stake by 44% in Q1 2026, selling an estimated $940M and leaving 15,392,222 shares worth $1.11B. The position accounts for 0.26% of the portfolio, ranked #91.

Capital International Investors first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.02B in Q1 2024. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Capital International Investors held 15,392,222 shares of CVS Health worth $1.11B as of Q1 2026.
Capital International Investors sold 12,200,134 CVS Health shares in Q1 2026, an estimated $940M.
CVS Health made up 0.26% of Capital International Investors's portfolio in Q1 2026, its #91 holding.
Capital International Investors first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
Capital International Investors's CVS Health position peaked at $3.02B in Q1 2024.
1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Capital International Investors's 13F filing for Q1 2026, filed 13 May 2026.